--- title: "Pre-market hot trades in US stocks: Digitalocean up 15.32% in pre-market; Onconetix down 11.15% in pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/291938664.md" description: "Digitalocean pre-market up 15.32%; Onconetix pre-market down 11.15%; Crinetics Pharmaceuticals pre-market up 98.86%; CCH pre-market up 65.59%; Trident Digital Tech pre-market up 65.38%" datetime: "2026-07-07T13:07:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291938664.md) - [en](https://longbridge.com/en/news/291938664.md) - [zh-HK](https://longbridge.com/zh-HK/news/291938664.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Digitalocean up 15.32% in pre-market; Onconetix down 11.15% in pre-market **Popular Pre-Market Trades in US Stocks** Digitalocean, up 15.32% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Onconetix is down 11.15% in pre-market trading. Based on recent news, 1. On July 7, Onconetix announced it would acquire Realbotix LLC through an all-stock exchange. The transaction is expected to be completed in the second half of 2026, subject to shareholder votes, regulatory approvals, and other closing conditions. This news raised market concerns, leading to a significant drop in the stock price. 2. On July 6, the market expressed concerns about Onconetix's acquisition plan, believing that the transaction could negatively impact the company's financial condition, further exacerbating the decline in stock price. 3. On July 5, analysts downgraded their earnings expectations for Onconetix, anticipating that the company's profitability would be challenged in the coming quarters, leading to weakened investor confidence. The market showed concerns about the acquisition plan, with noticeable capital outflows. **Top Gainers in Pre-Market Trading in US Stocks** Crinetics Pharmaceuticals is up 98.86% in pre-market trading. Based on recent key news: 1. On July 7, Fortress Biotech announced it would acquire Crinetics Pharmaceuticals for approximately $10 billion, significantly enhancing its presence in the rare endocrine disease sector. Following this news, Crinetics' stock surged nearly 99% in pre-market trading. Fortress will acquire all outstanding shares of Crinetics at $85 per share, with the transaction expected to close in the third quarter. Source: Zhitong Finance 2. On July 7, Fortress Biotech stated that the acquisition of Crinetics would boost the company's adjusted operating profit in 2029. Crinetics' core product PALSONIFY and the candidate drug atumelnant are expected to have combined peak annual sales exceeding $5 billion. Source: Zhitong Finance 3. On July 7, analysts changed their ratings on Crinetics. Oppenheimer analyst Leland Gershell downgraded Crinetics from outperform to market perform, while Cantor Fitzgerald analyst Josh Schimmer also downgraded the rating from overweight to neutral. Source: Zhitong Finance Fortress Biotech's acquisition of Crinetics enhances its positioning in the endocrine disease sector. CCH is up 65.59% in pre-market trading. Based on recent news, 1. On July 7, CCH Holdings Ltd. announced that its wholly-owned subsidiary signed a three-year, $50 million sales and service agreement. The agreement involves providing maintenance and technical support services for a data center project in Malaysia, with expectations to expand to other countries This initiative is expected to diversify revenue and support growth in the Southeast Asian region. 2. On July 7, CCH Holdings Ltd. announced details on how factors such as changes in demand in the data center industry, customer procurement plans, supply chain availability, foreign exchange fluctuations, execution risks, competitive pressures, regulatory developments, and general economic conditions have impacted the company's performance. 3. On July 7, CCH Holdings Ltd. positioned itself to provide data center infrastructure maintenance services through a significant transaction. This move enables the company to support its core food and beverage franchising business while ensuring operational stability. Changes in demand in the data center industry and growth potential in Southeast Asia. Trident Digital Tech pre-market rose 65.38%. Based on recent key news: 1. On July 7, Trident announced a restructuring to support its growth phase, which is expected to enhance financial flexibility for strategic acquisitions and corporate AI commercialization. This move drove the stock price up by 66.48%. Source: Benzinga 2. On July 7, despite the stock price increase, Trident has fallen 79.78% year-to-date and 77.42% over the past 12 months. Today's trading volume surged to 18.8 million shares, far exceeding the three-month average daily trading volume. Source: Benzinga 3. On July 6, the company announced a 240-for-1 reverse stock split, terminated the ADS program, and transitioned to trading common stock on NASDAQ. This move aims to optimize the shareholder structure. Source: Company news AI industry expansion, active market trading, and attention to risks ### Related Stocks - [DOCN.US](https://longbridge.com/en/quote/DOCN.US.md) - [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md) - [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md) - [CCHH.US](https://longbridge.com/en/quote/CCHH.US.md) - [TDTH.US](https://longbridge.com/en/quote/TDTH.US.md) ## Related News & Research - [Looking Beyond the Cloud Giants? Analysts Say Buy These 2 Overlooked Stocks](https://longbridge.com/en/news/297766026.md) - [DigitalOcean to Participate in Citi’s 2026 Global TMT Conference | DOCN Stock News](https://longbridge.com/en/news/297810230.md) - [New Mexico Educational Retirement Board Invests $2.67 Million in DigitalOcean Holdings, Inc. $DOCN](https://longbridge.com/en/news/297422580.md) - [DigitalOcean (NYSE:DOCN) Coverage Initiated by Analysts at Truist Financial](https://longbridge.com/en/news/297189878.md) - [DigitalOcean to Participate in Goldman Sachs Communacopia + Technology Conference 2026 | DOCN Stock News](https://longbridge.com/en/news/297677248.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**